Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann R Coll Surg Engl ; 98(6): 396-400, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27138851

RESUMO

Introduction Operable oesophagogastric adenocarcinoma management in the UK includes three cycles of neoadjuvant chemotherapy (NAC) followed by resection. Determination of oxygen uptake at the anaerobic threshold (AT) with cardiopulmonary exercise testing (CPET) is used to objectively measure cardiorespiratory reserve. Oxygen uptake at AT predicts perioperative risk, with low values associated with increased morbidity. Previous studies indicate NAC may have a detrimental impact on cardiorespiratory reserve. Methods CPET was completed by 30 patients before and after a standardised NAC protocol. The ventilatory AT was determined using the V-slope method, and the peak oxygen uptake and ventilatory equivalents for carbon dioxide measured. Median AT before and after chemotherapy was compared using a paired Student's t-test. Results Median oxygen uptake at AT pre- and post-NAC was 13.9±3.1 ml/kg/min and 11.5±2.0 ml/kg/min, respectively. The mean decrease was 2.4 ml/kg/min (95% confidence interval [CI] 1.3-3.85; p<0.001). Median peak oxygen delivery also decreased by 2.17 ml/kg/min (95% CI 1.02-3.84; p=0.001) after NAC. Ventilatory equivalents were unchanged. Conclusions This reduction in AT objectively quantifies a decrease in cardiorespiratory reserve after NAC. Patients with lower cardiorespiratory reserve have increased postoperative morbidity and mortality. Preventing this decrease in cardiorespiratory reserve during chemotherapy, or optimising the timing of surgical resection after recovery of AT, may allow perioperative risk-reduction.


Assuntos
Adenocarcinoma/terapia , Aptidão Cardiorrespiratória/fisiologia , Neoplasias Esofágicas/terapia , Terapia Neoadjuvante , Consumo de Oxigênio/fisiologia , Neoplasias Gástricas/terapia , Adenocarcinoma/fisiopatologia , Idoso , Limiar Anaeróbio/fisiologia , Protocolos de Quimioterapia Combinada Antineoplásica , Cisplatino/administração & dosagem , Epirubicina/administração & dosagem , Neoplasias Esofágicas/fisiopatologia , Teste de Esforço , Fluoruracila/administração & dosagem , Humanos , Complicações Pós-Operatórias , Estudos Retrospectivos , Neoplasias Gástricas/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...